Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1


Medical Devices

Pulmonx

Pulmonx's headquarters in Redwood City, CA, United States

The Neuchâtel office focuses on financial management and strategic sales leadership for the EMEA region.

Neuchâtel

Glendon E. French

Myung Kil

Sonya Brown Babcock

Lauren Cristina

Beran Rose

Jérôme Erath

Narinder Singh Shargill

Martin Schneider

Lisa Paul

David Lehman

Sri Radhakrishnan

Dana G. Mead

Thomas W. Burns

Richard Ferrari

Georgia Garinois-Melenikiotou

Daniel P. Florin

Tiffany Sullivan

Alissa Hsu Lynch

This department focuses on managing and executing sales strategies across designated territories to drive revenue growth.

Sales Management

The Sales Team at Pulmonx is responsible for promoting and selling the Zephyr Endobronchial Valve to healthcare providers. They engage in relationship-building with pulmonologists, hospitals, and medical centers to drive product adoption and increase market share. Through education, training, and support, they aim to ensure successful implementation of the valve, ultimately helping improve the quality of life for patients with COPD/emphysema.

Sales Team

The Leadership Team at Pulmonx is responsible for setting the strategic direction and overseeing the implementation of the company's vision to improve the treatment of COPD/emphysema through the Zephyr Endobronchial Valve. This team coordinates efforts across various functions, including commercial strategies, regulatory compliance, patient access, and global marketing, ensuring that the company's innovative solution meets market needs while maintaining high standards of quality and safety. Together, they drive Pulmonx’s growth and position within the healthcare landscape.

Leadership Team

The Marketing team at Pulmonx strategically promotes the Zephyr Endobronchial Valve to healthcare providers and potential patients. They analyze market data to shape campaigns, manage clinical marketing and education efforts, oversee digital marketing initiatives, and coordinate regional marketing operations in EMEA and Australia. The team works to enhance product awareness, drive adoption, and communicate the benefits of the treatment through various channels, ensuring consistent and impactful messaging across global markets.

Marketing

This department focuses on driving growth and establishing strategic partnerships in various regions.

Business Development

The Regulatory and Clinical Affairs team at Pulmonx is responsible for ensuring compliance with medical regulations, obtaining necessary approvals, and managing clinical studies for the Zephyr Endobronchial Valve. They work on the design, implementation, and management of clinical trials, analyze clinical data, oversee quality assurance processes, and manage health economics and reimbursement strategies to support the product's global availability and adoption.

Pulmonx

Org chart

Board & advisors

Teams

Sales Management

Sales Team

Leadership Team

Marketing

Business Development

Regulatory and Clinical Affairs

Offices

Pulmonx

Org chart

Board & advisors

Teams

Sales Management

Sales Team

Leadership Team

Marketing

Business Development

Regulatory and Clinical Affairs

Offices

Related companies